Crinetics Pharmaceuticals (CRNX)
(Delayed Data from NSDQ)
$43.01 USD
-1.00 (-2.27%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $43.03 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
CRNX 43.01 -1.00(-2.27%)
Will CRNX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CRNX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CRNX
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Crinetics (CRNX) Up as Second Acromegaly Study Meets Goals
CRNX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Crinetics Pharmaceuticals (CRNX) Stock Jumps 19.1%: Will It Continue to Soar?
Xencor (XNCR) Reports Q4 Loss, Misses Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
Other News for CRNX
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Biotech Alert: Searches spiking for these stocks today
Crinetics Pharmaceuticals Launches New Deferred Compensation Plan
Crinetics Pharmaceuticals gains amid pitch at Sohn charity conference (update)
Crinetics Pharmaceuticals gains amid pitch at Sohn charity conference